Loading…
Attending this event?
Back To Schedule
Tuesday, September 20 • 9:45am - 10:30am
Panel: Leverage AI and ML to Advance Discovery and Accelerate Drug Development

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Developing a therapeutic on average takes 12+ years and billions of dollars, but now with AI and machine learning, the potential to identify molecules and bring them to the clinic faster and cheaper can be a reality. But where has there been proven success applying AI and ML and does it live up to the hype?

Speakers
avatar for Andrew A. Radin

Andrew A. Radin

Co-founder and CEO, Aria Pharmaceuticals
Andrew A. Radin is the co-founder and Chief Executive Officer of Aria Pharmaceuticals. Andrew created the company’s first drug development algorithms as part of his studies in biomedical informatics at Stanford University in 2014. Since co-founding Aria, Andrew was named an Emerging... Read More →
avatar for Molly Gibson, Ph.D

Molly Gibson, Ph.D

Co-founder, Chief Strategy and Chief Innovation Officer, Generate Biomedicines
Molly serves as co-founder and chief strategy and chief innovation officer of Generate Biomedicines, a Flagship Pioneering company. At Generate, she oversees corporate strategy, platform and data strategy, and an innovation group called G:Labs that explores novel applications of the... Read More →


Tuesday September 20, 2022 9:45am - 10:30am EDT